The global Gentamicin Active Pharmaceutical Ingredient (API) market is poised for a strong growth trajectory over the next ...

According to DataM Intelligence, the Active Pharmaceutical Ingredients Market Size reached US$ 238.7 Billion in 2024, up from ...

Active Pharmaceutical Ingredients (APIs), once considered a backend component of drug production, are now emerging as ...

Rising chronic diseases, biologics use, cancer cases, and advanced drug R&D are driving global API market growth and drug demand across regions. HYDERABAD, TELANGANA ...

DUBLIN--(BUSINESS WIRE)--The "United States Active Pharmaceutical Ingredients Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2024" report has been added to ...

Pharmaceutical contract manufacturing and API sourcing in Central Europe and the Balkan states 2011 is the latest report providing an in-depth analysis for pharmaceutical contract manufacturing and ...

President Donald Trump announced tariffs would apply to foreign pharmaceutical manufacturers starting Oct. 1 unless they were ...

HOUSTON — Eli Lilly and Co. (NYSE: LLY) has unveiled plans to build a new $6.5 billion manufacturing facility at Generation ...

The convergence of biopharmaceutical innovation, contract manufacturing partnerships, and advanced synthesis technologies is redefining how drugs are developed, manufactured, and delivered worldwide N ...